Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.16 AUD | +3.57% | +7.91% | -21.09% |
Valuation
Fiscal Period: June | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|
Capitalization 1 | 447.4 | 740.1 | 650.8 | - | - |
Enterprise Value (EV) 1 | 467 | 1,436 | 1,100 | 1,113 | 1,132 |
P/E ratio | - | - | - | - | - |
Yield | 5.45% | 5.8% | 6.92% | 7.11% | 7.62% |
Capitalization / Revenue | 15.4 x | 15.5 x | 9.87 x | 10.1 x | 9.63 x |
EV / Revenue | 16 x | 30.1 x | 16.7 x | 17.2 x | 16.7 x |
EV / EBITDA | 24.5 x | 48.5 x | 18 x | 16.2 x | 15.5 x |
EV / FCF | 19.8 x | 63.3 x | 50.9 x | 37.2 x | 20.7 x |
FCF Yield | 5.05% | 1.58% | 1.96% | 2.69% | 4.82% |
Price to Book | 0.68 x | 0.78 x | 0.68 x | 0.67 x | 0.66 x |
Nbr of stocks (in thousands) | 325,378 | 562,814 | 561,003 | - | - |
Reference price 2 | 1.375 | 1.315 | 1.160 | 1.160 | 1.160 |
Announcement Date | 8/11/22 | 8/14/23 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: Giugno | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|
Net sales 1 | 29.14 | 47.7 | 65.95 | 64.73 | 67.59 |
EBITDA 1 | 19.1 | 29.6 | 61.16 | 68.93 | 73.01 |
EBIT 1 | 17.47 | 29.6 | 62.34 | 69.55 | 72.78 |
Operating Margin | 59.94% | 62.05% | 94.52% | 107.44% | 107.67% |
Earnings before Tax (EBT) | 49.61 | - | - | - | - |
Net income | - | 20.2 | - | - | - |
Net margin | - | 42.35% | - | - | - |
EPS | - | - | - | - | - |
Free Cash Flow 1 | 23.59 | 22.7 | 21.6 | 29.9 | 54.6 |
FCF margin | 80.95% | 47.59% | 32.75% | 46.19% | 80.78% |
FCF Conversion (EBITDA) | 123.49% | 76.69% | 35.32% | 43.38% | 74.79% |
FCF Conversion (Net income) | - | 112.38% | - | - | - |
Dividend per Share 2 | 0.0750 | 0.0762 | 0.0802 | 0.0824 | 0.0883 |
Announcement Date | 8/11/22 | 8/14/23 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: June | 2022 S1 | 2022 S2 | 2023 S1 | 2023 S2 | 2024 S1 |
---|---|---|---|---|---|
Net sales 1 | 10.84 | 18.29 | - | - | 39.6 |
EBITDA 1 | - | - | - | 18.4 | 29.1 |
EBIT 1 | 4.423 | 11.39 | 10.6 | 18.4 | 29.1 |
Operating Margin | 40.79% | 62.25% | - | - | 73.48% |
Earnings before Tax (EBT) | - | - | - | - | - |
Net income | - | - | 1.542 | - | - |
Net margin | - | - | - | - | - |
EPS | - | - | 0.004700 | - | - |
Dividend per Share 2 | - | - | - | 0.0388 | 0.0400 |
Announcement Date | 2/17/22 | 8/11/22 | 2/16/23 | 8/14/23 | 2/12/24 |
Balance Sheet Analysis
Fiscal Period: June | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|
Net Debt 1 | 19.6 | 696 | 449 | 463 | 481 |
Net Cash position 1 | - | - | - | - | - |
Leverage (Debt/EBITDA) | 1.026 x | 23.52 x | 7.346 x | 6.71 x | 6.593 x |
Free Cash Flow 1 | 23.6 | 22.7 | 21.6 | 29.9 | 54.6 |
ROE (net income / shareholders' equity) | 2.42% | 2.52% | 5.39% | 4.94% | 5.16% |
ROA (Net income/ Total Assets) | - | 1.67% | 2.44% | 3.11% | 3.86% |
Assets | - | 1,209 | - | - | - |
Book Value Per Share 2 | 2.010 | 1.690 | 1.700 | 1.730 | 1.760 |
Cash Flow per Share 2 | 0.0700 | 0.0600 | 0.0400 | 0.0700 | 0.0800 |
Capex 1 | - | - | - | 1 | 2 |
Capex / Sales | - | - | - | 1.54% | 2.96% |
Announcement Date | 8/11/22 | 8/14/23 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-21.09% | 442M | |
+15.61% | 62.3B | |
+3.74% | 14.46B | |
+12.46% | 8.52B | |
-1.51% | 6.7B | |
+15.68% | 3.74B | |
+9.74% | 3.63B | |
+28.02% | 3.1B | |
-6.83% | 3.07B | |
-7.84% | 2.71B |
- Stock Market
- Equities
- HCW Stock
- Financials HealthCo Healthcare and Wellness REIT